Afuco™ Anti-Human GMAD ADCC Therapeutic Antibody, ADCC Enhanced
Anti-GMAD ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies that immunospecifically bind to GMAD have uses, for example, in the prevention and treatment of both insulin- and non insulin-dependent diabetes mellitus (like Type I and Type II diabetes) and other related disorders.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-309CL |
| Pricing | Inquiry |
| Host | Human |
| Target | GMAD |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C |